Incyte's (INCY) Jakafi Granted FDA Orphan Drug Designation in Graft Versus Host Disease
Go back to Incyte's (INCY) Jakafi Granted FDA Orphan Drug Designation in Graft Versus Host DiseaseIncyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 56.97 -0.15 (0.26%) | |||||
---|---|---|---|---|---|---|
Previous Close | $57.12 | 52 Week High | $118.49 | |||
Open | $57.25 | 52 Week Low | $55.00 | |||
Day High | $57.09 | P/E | N/A | |||
Day Low | $56.77 | EPS | $-0.56 | |||
Volume | 1,883,250 |